Real world data presented by @krchhabra group at #ASMBS2025 Weight loss after 2 years: ✴️ Gastric bypass: 26% ✴️ Sleeve gastrectomy: 23% ✴️ Tirzepatide: 8% ✴️ Semaglutide: 5%

From one of my upcoming lectures: ~90% of people living with obesity remain untreated.

AI Ambient listening! @npetcka2022 @EmoryUniversity @EdLinEmory @VNikolian @EricKnauerMD

🏆 Tirzepatide vs. Semaglutide The heavyweight bout we’ve all been waiting for—and it’s a TKO. - - - A new NEJM study just dropped the first head-to-head trial in people with obesity (no diabetes). Here’s how it played out over 72 weeks: 🥇 Tirzepatide (Zepbound) vs 🥈 Semaglutide (Wegovy) 🔹 –20.2% vs –13.7% weight loss → 47% greater relative reduction 🔹 20% on tirzepatide lost ≥30% of their body weight (triple the semaglutide rate!) 🔹 Waistline: –18.4 cm vs –13.0 cm 🔹 Sex matters: women in both arms lost ~6% more than men 📉 Responder rates (tirzepatide vs semaglutide): ✅ ≥10% loss: 81.6% vs 60.5% ✅ ≥15% loss: 64.6% vs 40.1% ✅ ≥20% loss: 48.4% vs 27.3% ✅ ≥25% loss: 31.6% vs 16.1% ⚠️ Side effects? Mostly GI. Mostly manageable. No new red flags. Bottom line: This isn’t incremental—it’s transformational. GLP-1 was the revolution. Tirzepatide is the next frontier. Let’s talk: Access. Equity. Long-term outcomes. Are formularies ready for this future? 🔗 Full NEJM study: nejm.org/doi/full/10.1056/NE… #Zepbound #Wegovy #Tirzepatide #Semaglutide #ObesityMedicine #GLP1 #GIP #NEJM #WeightLoss #HealthTech #DigitalHealth #MedTwitter h/t @scottisaacsmd for images.

POV You’re a med student driving the lap scope for the first time Your attending: “The horizon still isn't straight” You *panics in sunset 🌇🌇* This @BehindTheKnife video might help 👇

ENDOSURGERY #2: ENDOBARIATRICS Did you know you can do a sleeve with an endoscope? How cool is that 🕶️??! Find out if it is all it's cracked up to be watch some great footage 📹 👇🏼 app.behindtheknife.org/podca… Great work from our endosurgery team @SAyusoMD @CraftsTrevor @UjikiMike @briandunkinmd

🧵 IS BARIATRIC SURGERY DANGEROUS? Let’s look at the global data. Swipe through for a data-driven breakdown.

Great talk by Dr. Matthew Ballweg this morning on the role of hand assisted MIS techniques for elective #diverticulitis with lower rates of ostomy formation and decreased operating time #SWSC25 #MIS

Great talk on robotic surgery and MIS techniques increased utilization in emergency general surgery by Dr. Anderson #Roboticsurgery #EGS

Had the greatest team and we preserved through adversity. Thanks for the great weekend!

Great talk at the SAGES fellows course by @htjacks on social media

Let the ⁦@SAGES_Updates⁩ 6th annual Fellows Career Development Course begin!!! ⁦@IvyNHaskinsMD⁩

Having an awesome time at the annual SAGES MIS Fellows' Course in Nashville! Talented group of fellows and incredible Faculty--

The Arizona crew is learning a lot and having a great time at @ASMBS #asmbs2024 @UofAZSurgery @ImanGhaderi @SarahSohail89 @DillonGasper

Happy Graduation Day to our exceptional General Surgery Residents, Class of 2024! 🎓 We're thrilled to celebrate their achievements and the culmination of their rigorous training journey. Congrats, graduates! The future of surgery is bright 😎 #UofAZSurgery #FellowshipMatch

Today, we’re proud to announce the U.S. Food and Drug Administration (FDA) provided 510(k) clearance for da Vinci 5, our next-generation multiport robotic system.

Focus on console ergonomics - looks like @IntuitiveSurg nailed it with the #DaVinci5 system @SocSurgErgo @SurgErgonomics @jennyshaomd @urogabe @andrewswright @AndreaLMerrill @YewandeAlimiMD @HalletJulie